FLGT Fulgent Genetics, Inc. Stock Quote

FLGT [NASD]

Healthcare | Diagnostics & Research | USA

Index	-	P/E	6.21	EPS (ttm)	14.85	Insider Own	4.50%	Shs Outstand	28.83M	Perf Week	3.07%
Market Cap	2.67B	Forward P/E	27.49	EPS next Y	3.36	Insider Trans	-7.54%	Shs Float	19.08M	Perf Month	0.02%
Income	417.00M	PEG	-	EPS next Q	2.76	Inst Own	36.20%	Short Float	27.48%	Perf Quarter	19.77%
Sales	773.40M	P/S	3.45	EPS this Y	38.10%	Inst Trans	1.83%	Short Ratio	6.41	Perf Half Y	-16.51%
Book/sh	27.80	P/B	3.32	EPS next Y	-73.05%	ROA	81.60%	Target Price	87.00	Perf Year	253.18%
Cash/sh	14.18	P/C	6.51	EPS next 5Y	-	ROE	101.40%	52W Range	25.07 - 189.89	Perf YTD	77.06%
Dividend	-	P/FCF	8.16	EPS past 5Y	88.50%	ROI	36.50%	52W High	-50.68%	Beta	1.51
Dividend %	-	Quick Ratio	3.40	Sales past 5Y	113.20%	Gross Margin	79.30%	52W Low	273.57%	ATR	5.44
Employees	429	Current Ratio	3.40	Sales Q/Q	4536.00%	Oper. Margin	71.70%	RSI (14)	60.69	Volatility	5.46% 6.84%
Optionable	Yes	Debt/Eq	0.02	EPS Q/Q	-	Profit Margin	53.90%	Rel Volume	0.37	Prev Close	92.25
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Aug 05 AMC	Payout	0.00%	Avg Volume	817.77K	Price	93.65
Recom	2.50	SMA20	8.58%	SMA50	14.76%	SMA200	21.45%	Volume	233,041	Change	1.52%

Jan-08-21

Downgrade

Credit Suisse

Neutral → Underperform

$42 → $40

Nov-24-20

Downgrade

BTIG Research

Buy → Neutral

Aug-20-20

Initiated

Oppenheimer

Outperform

$75

May-29-20

Initiated

BTIG Research

Buy

$20

Nov-05-19

Upgrade

Piper Jaffray

Neutral → Overweight

Mar-01-18

Downgrade

Piper Jaffray

Overweight → Neutral

Nov-07-17

Downgrade

Raymond James

Outperform → Mkt Perform

Jul-26-21 10:59AM	Were Hedge Funds Right About Fulgent Genetics, Inc. (FLGT)? Insider Monkey
08:24AM	CORRECTING and REPLACING Fulgent Genetics to Announce Second Quarter 2021 Financial Results on Monday, August 9, 2021 Business Wire
Jul-19-21 04:45PM	Why Shares of Fulgent Genetics Rose 77% in the First Half of 2021 Motley Fool +9.79%
Jul-14-21 08:22AM	3 Things About Fulgent Genetics That Smart Investors Know Motley Fool -9.71%
Jul-13-21 09:48AM	3 Stocks I'd Buy if the Market Crashes Motley Fool -5.32%
Jul-04-21 05:20AM	What Is Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Share Price Doing? Simply Wall St.
Jun-29-21 06:08AM	Is It Too Late to Buy Fulgent Genetics Stock? Motley Fool +5.13%
Jun-24-21 07:05AM	3 Reasons I Just Bought Fulgent Genetics Stock Motley Fool
Jun-22-21 07:15PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CCXI, PRVB and WPG ACCESSWIRE
07:08PM	Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc. Newsfile
06:45PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI PR Newswire
03:40PM	CCXI ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 6, 2021 in the Class Action Filed on Behalf of ChemoCentryx, Inc. Limited Shareholders Newsfile
02:10PM	ARRY, CCXI, PCT, WISH SHAREHOLDERS - ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action lawsuits filed on behalf of Investors, Lead Plaintiff Deadlines Set ACCESSWIRE
01:46PM	HAGENS BERMAN Encourages ChemoCentryx (CCXI) Investors with Losses to Contact the Firm Before July 6 Deadline in Securities Class Action GlobeNewswire
11:42AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ChemoCentryx, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2021 - CCXI Newsfile
11:00AM	DEADLINE ALERT for CCXI, SKLZ, PCT, ATER: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
09:45AM	UPCOMING DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
05:34AM	CCXI LAWSUIT FILED: Jakubowitz Law Pursues Claims on Behalf of ChemoCentryx, Inc. Shareholders Newsfile
Jun-21-21 10:38PM	SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
09:23PM	ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages ChemoCentryx, Inc. Investors to Secure Counsel Before Important July 6 Deadline in Securities Class Action - CCXI PR Newswire
03:11PM	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of ChemoCentryx, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2021 - (CCXI) Newsfile
01:38PM	Shareholder Alert: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of ChemoCentryx, Inc. of Securities Class Action Lawsuit GlobeNewswire
01:30PM	INVESTOR ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action Lawsuits filed on behalf of ARRY, CCXI, PCT, WISH Investors, Lead Plaintiff Deadlines Set ACCESSWIRE
01:30PM	FINAL DEADLINE APPROACHING: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
01:28PM	CCXI LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving ChemoCentryx, Inc. Newsfile
12:00PM	DEADLINE ALERT for PINS, VWAGY, CCXI, and SKLZ: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:13AM	CCXI ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 6, 2021 in the Class Action Filed on Behalf of ChemoCentryx, Inc. Limited Shareholders Newsfile
11:00AM	VWAGY, CCXI & SKLZ Shareholder Alert: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm ACCESSWIRE
09:44AM	UPCOMING DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
05:56AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of ChemoCentryx, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 6, 2021 - CCXI Newsfile
Jun-20-21 01:23PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI GlobeNewswire
11:35AM	LAWSUITS FILED AGAINST CCXI, PRVB and FREQ - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
11:10AM	LAWSUITS FILED AGAINST CCXI, PCT and FREQ - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS ACCESSWIRE
Jun-19-21 02:30PM	ROSEN, NATIONAL TRIAL LAWYERS, Encourages ChemoCentryx, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important July 6 Deadline in Securities Class Action CCXI Business Wire
12:00PM	Class Action Lawsuit Deadline: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc. ACCESSWIRE
Jun-18-21 10:50PM	SHAREHOLDER ALERT: CLAIMSFILER REMINDS ARRY, CCXI, PCT, WISH INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits GlobeNewswire
07:30PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI ACCESSWIRE
04:37PM	CCXI Investor Reminder: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Against ChemoCentryx, Inc. Newsfile
02:04PM	CCXI ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 6, 2021 in the Class Action Filed on Behalf of ChemoCentryx, Inc. Limited Shareholders Newsfile
12:35PM	INVESTOR DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:55AM	HAGENS BERMAN Encourages ChemoCentryx (CCXI) Investors with Losses to Contact the Firm Now, Securities Fraud Action Pending Newsfile
11:15AM	CLASS ACTION UPDATE for CCXI, SKLZ and FREQ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:00AM	VWAGY, CCXI & SKLZ Shareholder Alert: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm ACCESSWIRE
10:11AM	8 High-Risk Stocks to Buy That Are Worth Taking a Chance On InvestorPlace
Jun-10-21 06:40AM	2 Stocks That Are More Likely to Double Your Money Than Dogecoin Motley Fool
Jun-08-21 06:10AM	What Does Life After COVID Look Like for Fulgent Genetics? Motley Fool
May-29-21 12:45PM	How Long Will Fulgent Genetics Benefit From the Pandemic? Motley Fool
04:44AM	We Think Fulgent Genetics (NASDAQ:FLGT) Can Manage Its Debt With Ease Simply Wall St.
May-18-21 05:49AM	Forget Dogecoin -- Buy These 3 Growth Stocks Instead Motley Fool
May-14-21 07:10AM	What Are Investors Thinking About Fulgent Genetics? Motley Fool
May-10-21 08:00AM	Fulgent Genetics Announces Incremental Strategic Investment in Chinese Joint Venture, FF Gene Biotech Business Wire -8.27%
May-07-21 06:08AM	Why Investors Loved Fulgent Genetics' Q1 Results Motley Fool
01:31AM	Fulgent Genetics, Inc. Common Stock (FLGT) Q1 2021 Earnings Call Transcript Motley Fool
May-06-21 04:05PM	Fulgent Genetics Reports Record First Quarter Financial Results Business Wire
02:45PM	Fulgent Genetics, Inc. to Host Earnings Call ACCESSWIRE
08:00AM	Fulgent Genetics Welcomes Dr. Lawrence Weiss as Chief Medical Officer Business Wire
May-05-21 01:28PM	Why Shares of Fulgent Genetics Fell 20% in April Motley Fool
Apr-30-21 09:26AM	What's in Store for Fulgent Genetics' (FLGT) Q1 Earnings? Zacks
Apr-27-21 06:24AM	2 Numbers That Explain How This Hypergrowth Company Can Make You Rich Motley Fool
Apr-24-21 06:35AM	3 Healthcare Stocks About to be Bolstered by Biden's American Rescue Plan Motley Fool
Apr-23-21 03:03AM	Calculating The Fair Value Of Fulgent Genetics, Inc. (NASDAQ:FLGT) Simply Wall St.
Apr-22-21 07:01AM	Which Stocks Are the Biggest Losers From Sinking COVID Testing Rates? Motley Fool
06:20AM	2 Unsustainable Growth Stocks to Avoid Motley Fool
Apr-20-21 07:21AM	Fulgent Genetics' CEO Just Told Investors To Look Out For An Acquisition Motley Fool
Apr-17-21 06:20AM	1 Number That Should Shock Fulgent Genetics Investors Motley Fool
Apr-16-21 08:00AM	Fulgent Genetics to Announce First Quarter 2021 Financial Results on Thursday May 6, 2021 GlobeNewswire
Apr-13-21 07:08AM	Got $5,000? These 2 Ultra-Cheap Stocks Are Bargain Buys Motley Fool +6.62%
Apr-09-21 06:15PM	The Bright Future Behind Genomic Sequencing InvestorPlace
Apr-05-21 08:37AM	Logitech, Harley-Davidson, Fulgent Genetics, Bio-Rad Laboratories and IDEXX Laboratories highlighted as Zacks Bull and Bear of the Day Zacks
Apr-03-21 06:02AM	3 Growing Healthcare Stocks to Buy and Hold for the Next 10 Years Motley Fool
Apr-01-21 09:18AM	COVID-19 Resurgence Accelerates Diagnostic Testing: 3 Top Picks Zacks
Mar-31-21 06:54AM	Why Fulgent Genetics Is a Great Stock to Buy Right Now Motley Fool
06:04AM	Have $5,000? Buying These 3 Stocks Could Be the Smartest Move You Ever Made Motley Fool
Mar-29-21 02:08PM	Is Fulgent Genetics (FLGT) A Smart Long-Term Buy? Insider Monkey
Mar-25-21 07:02AM	Where Does Fulgent Genetics Go From Here? Motley Fool
06:45AM	Buy These 3 Stocks to Cash In on the Genomics Revolution Motley Fool
Mar-24-21 06:20AM	2 Potential 10-Bagger Stocks Cathie Wood and ARK Don't Own Yet Motley Fool -7.67%
Mar-20-21 07:05AM	Could Fulgent Genetics Be a Millionaire-Maker Stock? Motley Fool
Mar-18-21 03:40AM	Is Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Shareholder Ownership Skewed Towards Insiders? Simply Wall St. -11.79%
Mar-16-21 08:17AM	The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study Benzinga
06:01AM	Which COVID Stocks Could Be Winners With the $1.9 Trillion Stimulus Package? Motley Fool
Mar-15-21 04:05PM	Fulgent Genetics Awarded Contract from CDC to Study Variants of COVID-19 Virus GlobeNewswire +9.07%
Mar-14-21 07:02AM	Should You Buy Fulgent Genetics Stock in March? Motley Fool
Mar-13-21 07:01AM	How Do Fulgent Genetics and Invitae Stack Up Against Each Other? Motley Fool
Mar-10-21 10:06AM	Zacks.com featured highlights include: Amkor Tech, Daqo New Energy Corp and Fulgent Genetics Zacks -11.28%
Mar-08-21 06:51AM	FULGENT GENETIC (FLGT) Moves 8% Higher: Will This Strength Last? Zacks
Mar-07-21 08:27AM	Can Fulgent Genetics Stock Rebound? Motley Fool
Mar-05-21 11:13AM	Why Fulgent Genetics Stock Temporarily Soared 31% Today Motley Fool +7.96%
08:00AM	Fulgent Genetics to Participate in the Oppenheimer 31st Annual Healthcare Conference GlobeNewswire
06:15AM	COVID Tester Fulgent Higher on Earnings Beat and Guidance TheStreet.com
06:01AM	How Fulgent Genetics Wowed With Its Q4 Results Motley Fool
Mar-04-21 11:30PM	Fulgent Genetics, Inc. Common Stock (FLGT) Q4 2020 Earnings Call Transcript Motley Fool -7.82%
05:40PM	These 2 Stocks Are Soaring Despite Another Market Plunge Motley Fool
04:58PM	Recap: Fulgent Genetics Q4 Earnings Benzinga
04:05PM	Fulgent Genetics Reports Record Fourth Quarter and Full Year 2020 Financial Results GlobeNewswire
02:30PM	Fulgent Genetics, Inc. to Host Earnings Call ACCESSWIRE
Mar-02-21 07:36AM	Better Buy: CRISPR vs. Fulgent Genetics Motley Fool -6.86%
Feb-28-21 07:33AM	Have $1,000? This Is the Best Coronavirus Stock to Buy Now Motley Fool
Feb-26-21 02:00PM	What's the Strongest Buy: Moderna, Teladoc Health, or Fulgent Genetics? Motley Fool
10:00AM	1 Green Flag for Fulgent Genetics Motley Fool

Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19 testing and genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves insurance, hospitals, and medical institutions. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. Fulgent Genetics has collaboration with PWNHealth to provide at-home COVID-19 test capabilities. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KIM PAUL	CFO and Treasurer	Jun 04	Sale	74.26	789	58,588	142,188	Jun 04 06:38 PM
BOLGER JOHN C	Director	Jun 03	Sale	74.17	125	9,271	2,000	Jun 07 05:25 PM
KIM PAUL	CFO and Treasurer	Jun 02	Sale	71.34	461	32,886	142,977	Jun 04 06:38 PM
BOLGER JOHN C	Director	Jun 01	Option Exercise	12.17	1,876	22,824	4,001	Jun 03 05:41 PM
BOLGER JOHN C	Director	Jun 01	Sale	71.41	1,876	133,966	2,125	Jun 03 05:41 PM
Xie Jian	Chief Operating Officer	May 28	Sale	73.46	647	47,527	337,394	Jun 02 04:45 PM
KIM PAUL	CFO and Treasurer	May 26	Sale	72.90	18,000	1,312,119	143,438	May 27 07:07 PM
KIM PAUL	CFO and Treasurer	May 25	Sale	72.94	10,358	755,479	161,438	May 27 07:07 PM
Xie Jian	Chief Operating Officer	May 25	Sale	72.21	2,000	144,412	338,041	May 27 06:58 PM
Xie Jian	Chief Operating Officer	May 20	Sale	74.48	1,000	74,480	340,041	May 20 08:50 PM
Xie Jian	Chief Operating Officer	May 18	Sale	70.71	931	65,831	341,041	May 20 08:50 PM
KIM PAUL	CFO and Treasurer	May 18	Sale	70.71	1,155	81,670	171,796	May 20 05:29 PM
Gao Hanlin	Chief Scientific Officer	May 18	Sale	70.71	315	22,274	816,273	May 20 05:27 PM
Xie Jian	Chief Operating Officer	Mar 15	Sale	104.10	3,000	312,300	342,476	Mar 17 05:09 PM
BOLGER JOHN C	Director	Mar 09	Option Exercise	5.24	3,124	16,384	3,499	Mar 11 05:19 PM
Xie Jian	Chief Operating Officer	Mar 09	Sale	102.65	62,000	6,364,219	345,476	Mar 11 05:13 PM
BOLGER JOHN C	Director	Mar 09	Sale	101.62	3,374	342,882	125	Mar 11 05:19 PM
KIM PAUL	CFO and Treasurer	Dec 10	Sale	51.94	16,958	880,734	174,563	Dec 11 06:26 PM
KIM PAUL	CFO and Treasurer	Dec 09	Sale	51.60	10,662	550,189	191,521	Dec 11 06:26 PM
KIM PAUL	CFO and Treasurer	Dec 02	Sale	46.58	29,949	1,395,133	202,183	Dec 04 04:06 PM
Xie Jian	Chief Operating Officer	Dec 02	Sale	46.00	1,000	46,000	431,689	Dec 02 06:03 PM
Xie Jian	Chief Operating Officer	Dec 01	Sale	45.16	1,000	45,160	432,689	Dec 02 06:03 PM
Xie Jian	Chief Operating Officer	Nov 30	Sale	43.22	3,396	146,762	433,689	Dec 02 06:03 PM
Xie Jian	Chief Operating Officer	Nov 23	Sale	44.08	6,000	264,480	437,085	Nov 24 05:24 PM
Xie Jian	Chief Operating Officer	Nov 20	Sale	42.50	1,000	42,500	443,085	Nov 24 05:24 PM
Xie Jian	Chief Operating Officer	Nov 18	Sale	44.83	3,000	134,500	444,085	Nov 19 08:15 PM
BOLGER JOHN C	Director	Nov 17	Option Exercise	0.38	2,631	1,000	4,644	Nov 18 07:48 PM
Gao Hanlin	Chief Scientific Officer	Nov 17	Sale	45.45	301	13,680	813,391	Nov 18 07:50 PM
BOLGER JOHN C	Director	Nov 17	Sale	44.24	4,269	188,877	375	Nov 18 07:48 PM
Xie Jian	Chief Operating Officer	Nov 17	Sale	45.34	3,706	168,012	447,085	Nov 19 08:15 PM
KIM PAUL	CFO and Treasurer	Nov 17	Sale	45.45	3,767	171,206	232,132	Nov 18 07:52 PM
KIM PAUL	CFO and Treasurer	Nov 16	Sale	46.17	100,000	4,616,980	235,899	Nov 18 07:52 PM
KIM PAUL	CFO and Treasurer	Sep 02	Sale	28.32	425	12,035	335,899	Sep 03 08:45 PM
Xie Jian	Chief Operating Officer	Aug 28	Sale	30.82	441	13,591	601,295	Sep 23 07:35 PM
KIM PAUL	CFO and Treasurer	Aug 19	Sale	44.16	25,407	1,122,039	335,774	Aug 19 09:14 PM
BOLGER JOHN C	Director	Aug 17	Option Exercise	12.31	2,631	32,393	5,927	Aug 19 09:09 PM
KIM PAUL	CFO and Treasurer	Aug 17	Sale	41.65	111,236	4,633,097	361,181	Aug 19 09:14 PM
Gao Hanlin	Chief Scientific Officer	Aug 17	Sale	41.11	1,308	53,772	1,281,351	Aug 19 09:11 PM
BOLGER JOHN C	Director	Aug 17	Sale	40.87	3,914	159,967	2,013	Aug 19 09:09 PM
KIM PAUL	CFO and Treasurer	Aug 11	Sale	42.06	1,396	58,712	472,417	Aug 12 04:28 PM
Xie Jian	Chief Operating Officer	Aug 03	Sale	27.86	1,976	55,055	601,736	Aug 05 08:57 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience